Hemolytic uremic syndrome in the setting of COVID-19 successfully treated with complement inhibition therapy: An instructive case report of a previously healthy toddler and review of literature

IntroductionAs the global pandemic continues, new complications of COVID-19 in pediatric population have turned up, one of them being hemolytic uremic syndrome (HUS), a complement-mediated thrombotic microangiopathy (CM-TMA) characterized by triad of thrombocytopenia, microangiopathic hemolytic anem...

Full description

Bibliographic Details
Published in:	Frontiers in Pediatrics
Main Authors:	Matija Matošević, Ivanka Kos, Maša Davidović, Maja Ban, Hana Matković, Ivan Jakopčić, Ivana Vuković Brinar, Ágnes Szilágyi, Dorottya Csuka, György Sinkovits, Zoltán Prohászka, Kristina Vrljičak, Lovro Lamot
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Subjects:	hemolytic uremic syndrome HUS thrombotic microangiopathy TMA COVID-19 complement blockade
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2023.1092860/full

Similar Items

Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal OutcomesPlain Language Summary
by: Natalja Haninger-Vacariu, et al.
Published: (2023-07-01)

Editorial: Cystic kidney diseases in children and adults: from diagnosis to etiology and back
by: Lovro Lamot, et al.
Published: (2024-04-01)

A case of hemolytic uremic syndrome following hysterosalpingiogram
by: Ahmed Mohamed Elhawy, et al.
Published: (2025-09-01)

Hemolytic uremic syndrome: Toxins, vessels, and inflammation
by: Howard eTrachtman
Published: (2014-11-01)

Validation of Early Increase in Complement Activation Marker sC5b-9 as a Predictive Biomarker for the Development of Thrombotic Microangiopathy After Stem Cell Transplantation
by: Blanka Mezö, et al.
Published: (2020-10-01)

Use of complement C5-inhibitor eculizumab in patients with infection-associated hemolytic uremic syndrome – a case-series report
by: Petra Varga, et al.
Published: (2025-03-01)

Single-Center Experience of Pediatric Cystic Kidney Disease and Literature Review
by: Sara Grlić, et al.
Published: (2024-03-01)

Eculizumab is efficacious and safe in pediatric patients with various forms of hemolytic uremic syndrome: a retrospective clinical experience of a tertiary center
by: Naama Lax, et al.
Published: (2025-04-01)

Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management
by: Mustafa N. Yenerel
Published: (2014-08-01)

Typical course of cystinuria leading to untypical complications in pregnancy: A case report and review of literature
by: Ema Ivandic, et al.
Published: (2023-04-01)

Thrombotic microangiopathy in children: Redefining hemolytic uremic syndrome, thrombotic thrombocytopenic purpura and related disorders
by: Mamta Manglani, et al.
Published: (2024-03-01)

Neurological Manifestations of Hemolytic Uremic Syndrome: A Comprehensive Review
by: Una Tonkovic, et al.
Published: (2025-07-01)

Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers
by: Iva Sorić Hosman, et al.
Published: (2023-11-01)

HELLP Syndrome and Differential Diagnosis with Other Thrombotic Microangiopathies in Pregnancy
by: Stefano Raffaele Giannubilo, et al.
Published: (2024-02-01)

Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy
by: Fei-Fei Chen, et al.
Published: (2023-12-01)

Application of eculizumab, a terminal complement inhibitor, in the management of atypical hemolytic uremic syndrome in a 14-month-old Chinese pediatric patient: a case report
by: Xin Wei, et al.
Published: (2024-07-01)

Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Case Report with <i>MCP</i> Gene Mutation and Successful Eculizumab Treatment
by: Alex Domínguez-Vargas, et al.
Published: (2024-01-01)

PLASMIC score to aid diagnosis of aHUS: an analysis of C5 inhibitor clinical trials and the PINC AI™ healthcare database
by: Miguel G. Uriol-Rivera, et al.
Published: (2025-05-01)

A Multicenter Study Evaluating the Discontinuation of Eculizumab Therapy in Children with Atypical Hemolytic Uremic Syndrome
by: Saeed AlZabali, et al.
Published: (2022-11-01)

Two sides of the same coin: a complex presentation of autosomal dominant tubulointerstitial kidney diseases: a literature review and case reports
by: Margareta Fistrek Prlic, et al.
Published: (2023-11-01)

Annual trends in atypical haemolytic uremic syndrome management in Japan and factors influencing early diagnosis and treatment: a retrospective study
by: Yoshitaka Tatematsu, et al.
Published: (2024-08-01)

Pediatric Atypical Hemolytic Uremic Syndrome Advances
by: Rupesh Raina, et al.
Published: (2021-12-01)

Camptodactyly and Clinodactyly – New Understanding of Known Deformities
by: Matija Matošević, et al.
Published: (2021-01-01)

The outcome of thrombotic microangiopathy in kidney transplant recipients
by: Kanza Haq, et al.
Published: (2024-11-01)

Living with Atypical Hemolytic Uremic Syndrome in the Netherlands: Patient and Family Perspective
by: Romy N. Bouwmeester, et al.
Published: (2024-07-01)

Association of thrombotic microangiopathy with interferon therapy for hepatitis B: a case report
by: Shan Wei, et al.
Published: (2024-07-01)

Real-world outcomes of spinal muscular atrophy treatment with onasemnogene abeparvovec in Croatia: a comprehensive case series and literature review
by: Ivan Lehman, et al.
Published: (2025-06-01)

Pseudo-Thrombotic Microangiopathy (Pseudo-TMA): a rare manifestation of vitamin B12 deficiency in a child
by: Mohd Arif, et al.
Published: (2025-06-01)

Practical approach to thrombocytopenia in patients with sepsis: a narrative review
by: Kasumi Satoh, et al.
Published: (2024-07-01)

Cathelicidin in Urinary Tract Diseases: Diagnostic, Prognostic and Therapeutic Potential of an Evolutionary Conserved Antimicrobial Protein
by: Iva Sorić Hosman, et al.
Published: (2024-12-01)

Mixed Retinopathy: A Unique Presentation
by: Pushkar Dhir, et al.
Published: (2019-04-01)

Drug-induced de novo thrombotic microangiopathy diagnosed 2 years after renal transplantation: a case report and literature review
by: Keisuke Ozaki, et al.
Published: (2023-01-01)

Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS—Case Report
by: A. Inkeri Lokki, et al.
Published: (2020-04-01)

Ex vivo C5b-9 Deposition Test to Monitor Complement Activity in Clinical and Subclinical Atypical Hemolytic Uremic Syndrome and in Transplantation-Associated Thrombotic Microangiopathy
by: Maria Martin, et al.
Published: (2024-07-01)

Thrombotic microangiopathy multidisciplinary assessment team: demographics, final diagnosis, treatment, and outcomes
by: Matthew Nguyen, et al.
Published: (2025-09-01)

Delayed Onset of Thrombotic Microangiopathy (TMA) upon Prolonged Carfilzomib Therapy in Multiple Myeloma: A Case Report and Comprehensive Review
by: Andrea Ceglédi, et al.
Published: (2024-12-01)

Case report: Successful treatment of renal-limited thrombotic microangiopathy secondary to chronic lymphocytic leukemia
by: Kristina Nasr, et al.
Published: (2024-08-01)

A case of hemolytic-uremic syndrome that developed in a 5-year-old child due to acute intestinal infection with hemocolitis
by: O. V. Molochkova, et al.
Published: (2024-03-01)

Effect of blood groups on acquired and congenital thrombotic thrombocytopenic purpura and clinical correlation: Multi-center Turkish cohort study
by: Cevat İlteriş Kıkılı, et al.
Published: (2025-01-01)

Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports
by: Ping-Chih Hsu, et al.
Published: (2023-01-01)